Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis products.
Related Posts
CFPB drops lawsuit against JPMorgan Chase, Bank of America and Wells Fargo over Zelle fraud
Since Acting Director Russell Vought has taken over the CFPB, the agency has dropped at least a half dozen cases brought by his predecessor, Rohit […]
Goldman says buy this LGBTQ dating stock with more than 25% upside
Shares of Grindr may be due for some major gains over the next 12 months, according to Goldman Sachs.
Fed officials are worried about tariffs’ impact on inflation and see rate cuts on hold, minutes show
The Federal Reserve on Wednesday released minutes from its January meeting.